Showing 35,231 articles by Roger Pebody

Filters Author: Roger Pebody

Roger joined NAM in 2008 as an Editor and became Managing Editor in 2018. He is responsible for co-ordinating the editorial content of aidsmap.com, including news coverage and patient information materials. His involvement in HIV work began at Gay Men Fighting AIDS in the mid-1990s. Twitter: @RogerPebody

PrEP

Psychological impact of PrEP: beyond efficacy and cost-effectiveness

Editor's pick
HIV i-Base
6 October 2017
Sexually transmitted infections epidemiology

CDC: Rising PrEP Use Will Likely Drive Down STIs in Gay & Bi Men

Editor's pick
Poz
6 October 2017
PrEP

Why Prep Needs To Be Free For Everyone Right Now

Editor's pick
Huffington Post (video)
6 October 2017
Hepatitis C treatment

Egypt launches aggressive campaign to stamp out hepatitis C

Editor's pick
FRANCE 24
6 October 2017
Pharmaceutical industry

UK pharma denied legal challenge to drugs bill cap

Editor's pick
Pharmaphorum
5 October 2017
UK health services

Hep C: An end in sight?

Editor's pick
Drink & Drug News
5 October 2017
Women

Let's Advance the Conversation Among Black Women on HIV and PrEP

Editor's pick
The Body Pro
5 October 2017
Access to healthcare

Hepatitis C Drug’s Lower Cost Paves Way For Medicaid, Prisons To Expand Treatment

Editor's pick
Kaiser Health News
5 October 2017
Cardiovascular disease

People with HIV/HCV co-infection have an increased risk of cardiovascular disease compared to people with HIV alone

News
5 October 2017
Pharmaceutical industry

The Hepatitis Drug Market Is Worse Than Wall Street Realises

Editor's pick
Bloomberg
4 October 2017
New & experimental HIV treatments

Bictegravir-Containing Regimen Found to Be Non-Inferior to Boosted Protease Inhibitor-based Regimens in Virologically Suppressed Adult Patients with HIV

Editor's pick
Gilead press release
4 October 2017
Epidemiology & behaviour

Why are straight black women in Philly at high risk of HIV? Map offers clues

Editor's pick
Philly.com
4 October 2017
The search for a cure

New approach for AIDS: Lock HIV in reservoir cells, to die through apoptosis

Editor's pick
Science Daily
4 October 2017
Clinical trials

PrEP presents questions for HIV prevention researchers, survey seeks answers

Editor's pick
Science Speaks
4 October 2017
Finance & funding

Appropriations committees in U.S. Congress vote to maintain funding for Global Fund and PEPFAR

Editor's pick
Global Fund Observer
4 October 2017
Cancer

Gay Men May Be Able to Self-Check for Anal Cancer

Editor's pick
Poz
4 October 2017
Access to healthcare

The Medicines Patent Pool and Gilead Sciences Sign Licence for Bictegravir

Editor's pick
Medicines Patent Pool
4 October 2017
Epidemiology & behaviour

HIV rates plummet in new data but not good news for everyone says NAT

Editor's pick
National AIDS Trust
4 October 2017
Epidemiology & behaviour

HIV diagnoses in the UK fell in gay men last year for the first time since the mid-1990s, Public Health England confirms

News
3 October 2017
Epidemiology & behaviour

Virally suppressed people have “effectively no risk” of transmitting HIV, says US CDC: but how many are suppressed?

News
3 October 2017
PrEP

PrEP - Getting HIV to ZERO: free event in London

Editor's pick
56 Dean St
3 October 2017
Nutrition

Drinking three or more cups of coffee a day halves the risk of dying for people with HIV/HCV co-infection

News
3 October 2017
Global health initiatives

Is PEPFAR Leaving Behind Key Populations?

Editor's pick
MSMGF
2 October 2017
Diabetes

Many adults with diabetes delay insulin therapy

Editor's pick
Reuters
2 October 2017